SlideShare a Scribd company logo
Drug Abuse and HIV/AIDS Nora D. Volkow, M.D. Director National Institute on Drug Abuse
Estimated Number of AIDS Cases and Deaths  Among Adults and Adolescents By Exposure Category United States and Dependent Areas
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 0 5 10 15 20 25 30 35 40 Number of people living with HIV (millions) Year MSM Hetero, IDU MSM, Hetero, IDU MSM, Hetero, IDU IDU Hetero, IDU ↑ Estimated Number of Adults & Children Living With HIV IDU, Hetero Although It Has Improved in Some Places, Injection Drug Use Remains A Significant  HIV Transmission Mode In Many Regions of the World  Oceania Middle East & North Africa Eastern Europe & Central Asia Latin America and Caribbean North America and W & C Europe Asia Sub-Saharan Africa
 
Convergence of HIV Seroprevalence Among Injecting and Non-injecting Drug Users Current  Injectors Non-Injectors HIV Prevalence 13% CI 12-15% 12% CI 9-16% Drug Treatment Program (n=2121 2001-2004) Respondent-Driven Sampling  (n=448 2004) 15% CI 11-19% 17% CI 12-21% Source: Des Jarlais et al AIDS, 21: 231-235, 2007. Current  Injectors Non-Injectors 0 5 10 15 20 0 5 10 15 20
sober intoxicated (0.1 mg%) Drug and Alcohol Intoxication MARKEDLY Disrupt Brain Function: Effects of alcohol intoxication on brain metabolism
In Adults, Emotional Self Regulation Is Normally Implemented By A Neural Circuit Comprising Various  Prefrontal Regions …&  Subcortical  Limbic Structures Source: Beauregard, M. et al., Journal of Neuroscience 21 RC165, 2001. Sexual Arousal Condition Attempted Inhibition Condition Attempted Inhibition Condition
Alcohol decreases activity of areas involved with control and increases activity of areas involved with emotional reactivity Effects of Alcohol Intoxication on Brain Glucose Metabolism (Marker of Brain Function) Decreases prefrontal cortex cingulate gyrus Increases amygdala
In the United States, Minorities are Disproportionately Affected by HIV/AIDS Infection
Reported AIDS Cases, By Racial/Ethnic Group Cumulative Through 2006  United States and Dependent Areas
Estimated Number of Adults and Adolescents  Living with AIDS By Sex United States and Dependent Areas
Reported AIDS Cases, By Sex and Transmission Category,  Cumulative Through 2006  United States and Dependent Areas
HIV Seroconversion at 18 Months By Receipt of Treatment 0 5 10 15 20 25 Rate of Seroconversion (%) Treatment Status No treatment Partial treatment Continuous treatment Source: Metzger, D. S., Woody, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H., De Philipps, D., Stolley, P., & Abrutyn, E. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes, 6, 1049-1056. Among IDUs the Most Effective HIV/AIDS Prevention Strategy is  Drug Abuse Treatment
Although We Do Have Treatments That Work  We Face Some Major  Challenges  in Using Them ,[object Object],[object Object],[object Object],[object Object]
Future Research  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Depot Naltrexone  Comer, S.D., et al.  Arch Gen Psych, 63, 210-218, 2006. Visits (2 per week) 0% 10% 20% 30% 40% 50% 60% 70% 80% 0 2 4 6 8 10 12 14 16 18 % Negative Urines 192 mg Dose Placebo 384 mg Dose
Since Vaccine Strategies Have Not Yet Worked We Need to Focus More Efforts on  Prevention Strategies and their Implementation
 
Copyright restrictions may apply. Hall, H. I. et al. JAMA 2008;300:520-529. Estimated New Human Immunodeficiency Virus (HIV) Infections by Transmission Category,  Extended Back-Calculation Model, 50 US States and the District of Columbia, 1977-2006 80000 70000 60000 50000 40000 30000 20000 10000 0 1977- 1979 1980- 1981 1982- 1983 1984- 1985 1986- 1987 1988- 1990 1991- 1993 1994- 1996 1997- 1999 2000- 2002 2003- 2006 Period Injections MSM IDU MSM/IDU Heterosexual

More Related Content

What's hot

Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011 Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011
Camp Days
 
Voluntary Medical Male Circumsicion
Voluntary Medical Male CircumsicionVoluntary Medical Male Circumsicion
Voluntary Medical Male CircumsicionJack Jackson
 
2016 nevada hiv fast facts
2016 nevada hiv fast facts 2016 nevada hiv fast facts
2016 nevada hiv fast facts
#GOMOJO, INC.
 
Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)
Office of HIV Planning
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
UC San Diego AntiViral Research Center
 
Iryna Zablotska: Behavioural Surveillance: Testing And Sexual Behaviour
Iryna Zablotska: Behavioural Surveillance: Testing And Sexual BehaviourIryna Zablotska: Behavioural Surveillance: Testing And Sexual Behaviour
Iryna Zablotska: Behavioural Surveillance: Testing And Sexual Behaviour
Australian Federation of AIDS Organisations
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
UC San Diego AntiViral Research Center
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
UC San Diego AntiViral Research Center
 
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen BradyThe HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
Office of HIV Planning
 
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Office of HIV Planning
 
Chronic Kidney Disease Challenges and New Solutions
Chronic Kidney Disease Challenges and New SolutionsChronic Kidney Disease Challenges and New Solutions
Chronic Kidney Disease Challenges and New Solutions
Viewics
 
2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady
Office of HIV Planning
 
Basil Donovan: Syphilis epidemiology surveillance And HIV interactions
Basil Donovan: Syphilis epidemiology surveillance And HIV interactionsBasil Donovan: Syphilis epidemiology surveillance And HIV interactions
Basil Donovan: Syphilis epidemiology surveillance And HIV interactions
Australian Federation of AIDS Organisations
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Office of HIV Planning
 
Jeanne Zucker, Muscular Dystrophy Association
Jeanne Zucker, Muscular Dystrophy AssociationJeanne Zucker, Muscular Dystrophy Association
Jeanne Zucker, Muscular Dystrophy Association
Mad*Pow
 
Global and regional mortality from 235 causes of death for 20 age groups in 1...
Global and regional mortality from 235 causes of death for 20 age groups in 1...Global and regional mortality from 235 causes of death for 20 age groups in 1...
Global and regional mortality from 235 causes of death for 20 age groups in 1...
Institute for Health Metrics and Evaluation - University of Washington
 
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
UC San Diego AntiViral Research Center
 
Dr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic UpdateDr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic Update
Office of HIV Planning
 
SECURE-IBD Updates on COVID-19 and impact on IBD patients
SECURE-IBD Updates on COVID-19 and impact on IBD patientsSECURE-IBD Updates on COVID-19 and impact on IBD patients
SECURE-IBD Updates on COVID-19 and impact on IBD patients
Crohn's & Colitis Foundation
 
HIV Unplugged: Advances in Mobile Health
HIV Unplugged: Advances in Mobile Health HIV Unplugged: Advances in Mobile Health
HIV Unplugged: Advances in Mobile Health
UC San Diego AntiViral Research Center
 

What's hot (20)

Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011 Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011
 
Voluntary Medical Male Circumsicion
Voluntary Medical Male CircumsicionVoluntary Medical Male Circumsicion
Voluntary Medical Male Circumsicion
 
2016 nevada hiv fast facts
2016 nevada hiv fast facts 2016 nevada hiv fast facts
2016 nevada hiv fast facts
 
Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
 
Iryna Zablotska: Behavioural Surveillance: Testing And Sexual Behaviour
Iryna Zablotska: Behavioural Surveillance: Testing And Sexual BehaviourIryna Zablotska: Behavioural Surveillance: Testing And Sexual Behaviour
Iryna Zablotska: Behavioural Surveillance: Testing And Sexual Behaviour
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
 
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen BradyThe HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
 
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
 
Chronic Kidney Disease Challenges and New Solutions
Chronic Kidney Disease Challenges and New SolutionsChronic Kidney Disease Challenges and New Solutions
Chronic Kidney Disease Challenges and New Solutions
 
2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady
 
Basil Donovan: Syphilis epidemiology surveillance And HIV interactions
Basil Donovan: Syphilis epidemiology surveillance And HIV interactionsBasil Donovan: Syphilis epidemiology surveillance And HIV interactions
Basil Donovan: Syphilis epidemiology surveillance And HIV interactions
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
 
Jeanne Zucker, Muscular Dystrophy Association
Jeanne Zucker, Muscular Dystrophy AssociationJeanne Zucker, Muscular Dystrophy Association
Jeanne Zucker, Muscular Dystrophy Association
 
Global and regional mortality from 235 causes of death for 20 age groups in 1...
Global and regional mortality from 235 causes of death for 20 age groups in 1...Global and regional mortality from 235 causes of death for 20 age groups in 1...
Global and regional mortality from 235 causes of death for 20 age groups in 1...
 
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
 
Dr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic UpdateDr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic Update
 
SECURE-IBD Updates on COVID-19 and impact on IBD patients
SECURE-IBD Updates on COVID-19 and impact on IBD patientsSECURE-IBD Updates on COVID-19 and impact on IBD patients
SECURE-IBD Updates on COVID-19 and impact on IBD patients
 
HIV Unplugged: Advances in Mobile Health
HIV Unplugged: Advances in Mobile Health HIV Unplugged: Advances in Mobile Health
HIV Unplugged: Advances in Mobile Health
 

Similar to Wesat2201

Embargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbellEmbargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbell
OPUNITE
 
Patologie infettive e doppia diagnosi
Patologie infettive e doppia diagnosiPatologie infettive e doppia diagnosi
Patologie infettive e doppia diagnosi
Fabrizio Starace
 
Drug Abuse.ppt
Drug Abuse.pptDrug Abuse.ppt
Drug Abuse.ppt
Kharida2
 
NORA VOLKOW RX DRUG ABUSE | HEROIN SUMMIT 2016
NORA VOLKOW RX DRUG ABUSE | HEROIN SUMMIT 2016NORA VOLKOW RX DRUG ABUSE | HEROIN SUMMIT 2016
NORA VOLKOW RX DRUG ABUSE | HEROIN SUMMIT 2016
CENTRO DESINTOXICACIÓN IVATAD VALENCIA ADICCIONES
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
OPUNITE
 
Tue gs volkow
Tue gs volkowTue gs volkow
Tue gs volkow
OPUNITE
 
Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"
HopkinsCFAR
 
HIV, HCV, and TB Infection among Injection Drug Users in San Diego
HIV, HCV, and TB Infection among Injection Drug Users in San DiegoHIV, HCV, and TB Infection among Injection Drug Users in San Diego
HIV, HCV, and TB Infection among Injection Drug Users in San Diego
UC San Diego AntiViral Research Center
 
Opioid Use Disorder
Opioid Use Disorder Opioid Use Disorder
Opioid Use Disorder
Bryanna Harlan
 
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
ErikaAGoyer
 
Older, wiser & stronger - Aging Successfully with HIV
Older, wiser & stronger - Aging Successfully with HIVOlder, wiser & stronger - Aging Successfully with HIV
Older, wiser & stronger - Aging Successfully with HIV
NELSON VERGEL
 
Overview of HIV & Aging
Overview of HIV & AgingOverview of HIV & Aging
Sex- and Age-specific Increases in Suicide Attempts by Self-Poisoning in the ...
Sex- and Age-specific Increases in Suicide Attempts by Self-Poisoning in the ...Sex- and Age-specific Increases in Suicide Attempts by Self-Poisoning in the ...
Sex- and Age-specific Increases in Suicide Attempts by Self-Poisoning in the ...
Δρ. Γιώργος K. Κασάπης
 
Alcohol use and crash risk study
Alcohol use and crash risk studyAlcohol use and crash risk study
Alcohol use and crash risk study
Mr Christia
 
Hiv Case Study Presentation
Hiv Case Study PresentationHiv Case Study Presentation
Hiv Case Study Presentation
jeska62
 

Similar to Wesat2201 (20)

Embargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbellEmbargo version rx15_tt_wed_300_zibbell
Embargo version rx15_tt_wed_300_zibbell
 
Patologie infettive e doppia diagnosi
Patologie infettive e doppia diagnosiPatologie infettive e doppia diagnosi
Patologie infettive e doppia diagnosi
 
Drug Abuse.ppt
Drug Abuse.pptDrug Abuse.ppt
Drug Abuse.ppt
 
NORA VOLKOW RX DRUG ABUSE | HEROIN SUMMIT 2016
NORA VOLKOW RX DRUG ABUSE | HEROIN SUMMIT 2016NORA VOLKOW RX DRUG ABUSE | HEROIN SUMMIT 2016
NORA VOLKOW RX DRUG ABUSE | HEROIN SUMMIT 2016
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
HIV-1
HIV-1HIV-1
HIV-1
 
Opioids part1-2010
Opioids part1-2010Opioids part1-2010
Opioids part1-2010
 
Tue gs volkow
Tue gs volkowTue gs volkow
Tue gs volkow
 
Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"
 
HIV, HCV, and TB Infection among Injection Drug Users in San Diego
HIV, HCV, and TB Infection among Injection Drug Users in San DiegoHIV, HCV, and TB Infection among Injection Drug Users in San Diego
HIV, HCV, and TB Infection among Injection Drug Users in San Diego
 
HIVScreeningApproved
HIVScreeningApprovedHIVScreeningApproved
HIVScreeningApproved
 
Opioid Use Disorder
Opioid Use Disorder Opioid Use Disorder
Opioid Use Disorder
 
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
 
Older, wiser & stronger - Aging Successfully with HIV
Older, wiser & stronger - Aging Successfully with HIVOlder, wiser & stronger - Aging Successfully with HIV
Older, wiser & stronger - Aging Successfully with HIV
 
HIV Winnable Battle presentation
HIV Winnable Battle presentationHIV Winnable Battle presentation
HIV Winnable Battle presentation
 
Overview of HIV & Aging
Overview of HIV & AgingOverview of HIV & Aging
Overview of HIV & Aging
 
Sex- and Age-specific Increases in Suicide Attempts by Self-Poisoning in the ...
Sex- and Age-specific Increases in Suicide Attempts by Self-Poisoning in the ...Sex- and Age-specific Increases in Suicide Attempts by Self-Poisoning in the ...
Sex- and Age-specific Increases in Suicide Attempts by Self-Poisoning in the ...
 
Alcohol use and crash risk study
Alcohol use and crash risk studyAlcohol use and crash risk study
Alcohol use and crash risk study
 
SSDI & Opioid Use
SSDI & Opioid UseSSDI & Opioid Use
SSDI & Opioid Use
 
Hiv Case Study Presentation
Hiv Case Study PresentationHiv Case Study Presentation
Hiv Case Study Presentation
 

More from Mohamed Rafique

Live a carefree life!
Live a carefree life!Live a carefree life!
Live a carefree life!
Mohamed Rafique
 
Osy vulnerability stakeholder analysis
Osy vulnerability stakeholder analysisOsy vulnerability stakeholder analysis
Osy vulnerability stakeholder analysisMohamed Rafique
 
Knowledge sharing & communication mechanisms
Knowledge sharing & communication mechanismsKnowledge sharing & communication mechanisms
Knowledge sharing & communication mechanismsMohamed Rafique
 
Kathmandu presentation nabesh
Kathmandu presentation nabeshKathmandu presentation nabesh
Kathmandu presentation nabeshMohamed Rafique
 
How to add photos in ning
How to add photos in ningHow to add photos in ning
How to add photos in ningMohamed Rafique
 
Hivst is pptinhindibymodicarefoundation
Hivst is pptinhindibymodicarefoundationHivst is pptinhindibymodicarefoundation
Hivst is pptinhindibymodicarefoundationMohamed Rafique
 
For emphasis ci update 271010
For emphasis ci update 271010For emphasis ci update 271010
For emphasis ci update 271010Mohamed Rafique
 
Final presentation for bangladesh annual review meeting
Final presentation for bangladesh annual review meetingFinal presentation for bangladesh annual review meeting
Final presentation for bangladesh annual review meetingMohamed Rafique
 
Estimates of mobile population111
Estimates of mobile population111Estimates of mobile population111
Estimates of mobile population111Mohamed Rafique
 
Emphasis pres-sep 5-2010
Emphasis pres-sep 5-2010Emphasis pres-sep 5-2010
Emphasis pres-sep 5-2010Mohamed Rafique
 
Emphasis pres-sep 1-2010-12nb
Emphasis pres-sep 1-2010-12nbEmphasis pres-sep 1-2010-12nb
Emphasis pres-sep 1-2010-12nbMohamed Rafique
 
Emphasis pres-sep 1-2010-12
Emphasis pres-sep 1-2010-12Emphasis pres-sep 1-2010-12
Emphasis pres-sep 1-2010-12Mohamed Rafique
 
Emphasis pres-apr-9th-2010-11
Emphasis pres-apr-9th-2010-11Emphasis pres-apr-9th-2010-11
Emphasis pres-apr-9th-2010-11Mohamed Rafique
 
Emphasis pres-apr-9th-2010-1
Emphasis pres-apr-9th-2010-1Emphasis pres-apr-9th-2010-1
Emphasis pres-apr-9th-2010-1Mohamed Rafique
 
Emphasis steering committee
Emphasis steering committeeEmphasis steering committee
Emphasis steering committeeMohamed Rafique
 

More from Mohamed Rafique (20)

Live a carefree life!
Live a carefree life!Live a carefree life!
Live a carefree life!
 
Query formulation
Query formulationQuery formulation
Query formulation
 
Osy vulnerability stakeholder analysis
Osy vulnerability stakeholder analysisOsy vulnerability stakeholder analysis
Osy vulnerability stakeholder analysis
 
Ning addphotos
Ning addphotosNing addphotos
Ning addphotos
 
Knowledge sharing & communication mechanisms
Knowledge sharing & communication mechanismsKnowledge sharing & communication mechanisms
Knowledge sharing & communication mechanisms
 
Kathmandu presentation nabesh
Kathmandu presentation nabeshKathmandu presentation nabesh
Kathmandu presentation nabesh
 
How to add photos in ning
How to add photos in ningHow to add photos in ning
How to add photos in ning
 
Hivst is pptinhindibymodicarefoundation
Hivst is pptinhindibymodicarefoundationHivst is pptinhindibymodicarefoundation
Hivst is pptinhindibymodicarefoundation
 
For emphasis ci update 271010
For emphasis ci update 271010For emphasis ci update 271010
For emphasis ci update 271010
 
Final presentation for bangladesh annual review meeting
Final presentation for bangladesh annual review meetingFinal presentation for bangladesh annual review meeting
Final presentation for bangladesh annual review meeting
 
Estimates of mobile population111
Estimates of mobile population111Estimates of mobile population111
Estimates of mobile population111
 
Emphasis pres-sep 5-2010
Emphasis pres-sep 5-2010Emphasis pres-sep 5-2010
Emphasis pres-sep 5-2010
 
Emphasis pres-sep 1-2010-12nb
Emphasis pres-sep 1-2010-12nbEmphasis pres-sep 1-2010-12nb
Emphasis pres-sep 1-2010-12nb
 
Emphasis pres-sep 1-2010-12
Emphasis pres-sep 1-2010-12Emphasis pres-sep 1-2010-12
Emphasis pres-sep 1-2010-12
 
Emphasis pres-apr-9th-2010-11
Emphasis pres-apr-9th-2010-11Emphasis pres-apr-9th-2010-11
Emphasis pres-apr-9th-2010-11
 
Emphasis pres-apr-9th-2010-1
Emphasis pres-apr-9th-2010-1Emphasis pres-apr-9th-2010-1
Emphasis pres-apr-9th-2010-1
 
Emphasis
EmphasisEmphasis
Emphasis
 
Emphasis steering committee
Emphasis steering committeeEmphasis steering committee
Emphasis steering committee
 
Emphasis km process
Emphasis km processEmphasis km process
Emphasis km process
 
Emphasis km dream
Emphasis km dreamEmphasis km dream
Emphasis km dream
 

Recently uploaded

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 

Recently uploaded (20)

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 

Wesat2201

  • 1. Drug Abuse and HIV/AIDS Nora D. Volkow, M.D. Director National Institute on Drug Abuse
  • 2. Estimated Number of AIDS Cases and Deaths Among Adults and Adolescents By Exposure Category United States and Dependent Areas
  • 3. 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 0 5 10 15 20 25 30 35 40 Number of people living with HIV (millions) Year MSM Hetero, IDU MSM, Hetero, IDU MSM, Hetero, IDU IDU Hetero, IDU ↑ Estimated Number of Adults & Children Living With HIV IDU, Hetero Although It Has Improved in Some Places, Injection Drug Use Remains A Significant HIV Transmission Mode In Many Regions of the World Oceania Middle East & North Africa Eastern Europe & Central Asia Latin America and Caribbean North America and W & C Europe Asia Sub-Saharan Africa
  • 4.  
  • 5. Convergence of HIV Seroprevalence Among Injecting and Non-injecting Drug Users Current Injectors Non-Injectors HIV Prevalence 13% CI 12-15% 12% CI 9-16% Drug Treatment Program (n=2121 2001-2004) Respondent-Driven Sampling (n=448 2004) 15% CI 11-19% 17% CI 12-21% Source: Des Jarlais et al AIDS, 21: 231-235, 2007. Current Injectors Non-Injectors 0 5 10 15 20 0 5 10 15 20
  • 6. sober intoxicated (0.1 mg%) Drug and Alcohol Intoxication MARKEDLY Disrupt Brain Function: Effects of alcohol intoxication on brain metabolism
  • 7. In Adults, Emotional Self Regulation Is Normally Implemented By A Neural Circuit Comprising Various Prefrontal Regions …& Subcortical Limbic Structures Source: Beauregard, M. et al., Journal of Neuroscience 21 RC165, 2001. Sexual Arousal Condition Attempted Inhibition Condition Attempted Inhibition Condition
  • 8. Alcohol decreases activity of areas involved with control and increases activity of areas involved with emotional reactivity Effects of Alcohol Intoxication on Brain Glucose Metabolism (Marker of Brain Function) Decreases prefrontal cortex cingulate gyrus Increases amygdala
  • 9. In the United States, Minorities are Disproportionately Affected by HIV/AIDS Infection
  • 10. Reported AIDS Cases, By Racial/Ethnic Group Cumulative Through 2006 United States and Dependent Areas
  • 11. Estimated Number of Adults and Adolescents Living with AIDS By Sex United States and Dependent Areas
  • 12. Reported AIDS Cases, By Sex and Transmission Category, Cumulative Through 2006 United States and Dependent Areas
  • 13. HIV Seroconversion at 18 Months By Receipt of Treatment 0 5 10 15 20 25 Rate of Seroconversion (%) Treatment Status No treatment Partial treatment Continuous treatment Source: Metzger, D. S., Woody, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H., De Philipps, D., Stolley, P., & Abrutyn, E. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes, 6, 1049-1056. Among IDUs the Most Effective HIV/AIDS Prevention Strategy is Drug Abuse Treatment
  • 14.
  • 15.
  • 16. Since Vaccine Strategies Have Not Yet Worked We Need to Focus More Efforts on Prevention Strategies and their Implementation
  • 17.  
  • 18. Copyright restrictions may apply. Hall, H. I. et al. JAMA 2008;300:520-529. Estimated New Human Immunodeficiency Virus (HIV) Infections by Transmission Category, Extended Back-Calculation Model, 50 US States and the District of Columbia, 1977-2006 80000 70000 60000 50000 40000 30000 20000 10000 0 1977- 1979 1980- 1981 1982- 1983 1984- 1985 1986- 1987 1988- 1990 1991- 1993 1994- 1996 1997- 1999 2000- 2002 2003- 2006 Period Injections MSM IDU MSM/IDU Heterosexual

Editor's Notes

  1. The proportional distribution of AIDS cases by transmission category has shifted since the beginning of the epidemic. In 1985, male-to-male sexual contact accounted for 64% of all AIDS cases; in 2006, this transmission category accounted for 43% of all AIDS cases. The proportion of AIDS cases attributed to injection drug use increased during 1985–1994 and then slightly decreased, accounting for 19% of cases in 2006. The proportion of AIDS cases attributed to male-to-male sexual contact and injection drug use decreased from 9% in 1985 to 5% in 2006. The proportion of AIDS cases attributed to high-risk heterosexual contact increased from 3% in 1985 to 32% in 2006. The remaining AIDS cases were those attributed to hemophilia or the receipt of blood or blood products and those in persons without an identified risk factor. The data have been adjusted for reporting delays and cases without risk factor information were proportionally redistributed.
  2. The proportional distribution of AIDS cases among racial/ethnic groups has changed since the beginning of the epidemic. The proportion of AIDS cases in whites (not Hispanic) has decreased while the proportions in blacks (not Hispanic) and Hispanics have increased. The proportion of AIDS cases among Asians/Pacific Islanders and American Indians/Alaska Natives has remained relatively constant, at approximately 1% of all cases. Of persons diagnosed with AIDS in the United States and dependent areas in 2006, 48% were black, 29% were white, 21% were Hispanic, 1% were Asian/Pacific Islander, and less than 1% were American Indian/Alaska Native. The data have been adjusted for reporting delays. Slides containing more information on HIV and AIDS in racial and ethnic minorities are available at http://www.cdc.gov/hiv/topics/surveillance/resources/slides/race-ethnicity/index.htm.
  3. This slide shows increases in the number of adults and adolescents living with AIDS in the United States and dependent areas from 1993 through 2006. The increase is due primarily to the widespread use of highly active antiretroviral therapy, introduced in 1996, which has delayed the progression of AIDS to death. At the end of 2006, an estimated 447,720 adults and adolescents were living with AIDS; of these, 77% were males and 23% were females. The data have been adjusted for reporting delays.
  4. Of AIDS cases diagnosed in 2006 among male adults and adolescents, 59% were attributed to male-to-male sexual contact and 16% were attributed to injection drug use. Approximately 17% of cases were attributed to high-risk heterosexual contact and 7% were attributed to male-to-male sexual contact and injection drug use. Most (73%) of the AIDS cases diagnosed in 2006 among female adults and adolescents were attributed to high-risk heterosexual contact, and 24% were attributed to injection drug use. The data have been adjusted for reporting delays and cases without risk factor information were proportionally redistributed.